Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit

Growth Hormone and IGF Research

Volumn 18, Issue 1, 2008, Pages 65-74

  Hwang, David L ^a   Lee, Phillip D K ^b   Cohen, Pinchas ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMD SERONO INC   (United States)

Author keywords

Acid labile subunit; Insulin like growth factor binding protein; Insulin like growth factor I; Mouse insulin like growth factor

Indexed keywords

REAGENT; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN RELATED ACID LABILE SUBUNIT; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOASSAY; MALE; MOUSE; NONHUMAN; ONTOGENY; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SEXUAL MATURATION; VALIDATION PROCESS;

ANIMALS; CARRIER PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; MICE, INBRED STRAINS; TIME FACTORS;

EID: 38949205012     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.07.007     Document Type: Article

References (37)

1. Denley A., Cosgrove L.J., Booker G.W., Wallace J.C., and Forbes B.E. Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 16 (2005) 421-439
2. Firth S., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr. Rev. 23 (2002) 824-854
3. Cohen P. Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age. Endocrinology 147 (2006) 2109-2111
4. Domene H.N., Bengolea S.V., Jasper H.G., and Boisclair Y.R. Acid-labile subunit deficiency: phenotypic differences and similarities between human and mouse. J. Endocrinol. Invest. 28 suppl 5 (2005) 43-46
5. Silha J.V., and Murphy L.J. Insights from insulin-like growth factor binding protein transgenic mice. Endocrinology 143 (2002) 35-47
6. Yakar S., Sun H., Zhao H., Pennisi P., Toyoshima Y., Setser J., Stannard B., Scavo L., and LeRoith D. Metabolic effects of IGF-I deficiency: lessons from mouse models. Pediatr. Endocrinol. Rev. 3 (2005) 11-19
7. Lee P.D., Baker B.K., Liu F., Kwan E.Y., and Hintz R.L. A homologous radioimmunoassay for rat insulin-like growth factor-I (IGF-I): implications for studies of human IGF-I physiology. J. Clin. Endocrinol. Metab. 81 (1996) 2002-2005
8. Liu F., Hintz R.L., Khare A., Diaugustine R.P., Powell D.R., and Lee P.D.K. Immunoblot studies of the IGF-related acid-labile subunit. J. Clin. Endocrinol. Metab. 79 (1994) 1883-1886
9. Stadler S., Wu Z., Dressendorfer R.A., Morrison K.M., Khare A., Lee P.D.K., and Strasburger C.J. Monoclonal anti-acid-labile subunit oligopeptide antibodies and their use in a two-site immunoassay for ALS measurement in humans. J. Immuno. Meth. 252 (2001) 73-82
10. Watson C.S., Bialek P., Anzo M., Khosravi J., and Han V.K. Elevated circulating insulin-like growth factor binding protein-1 is sufficient to cause fetal growth restriction. Endocrinology 147 (2006) 1175-1186
11. Yakar S., Bouxsein M.L., Canalis E., et al. The ternary IGF complex influences postnatal bone acquisition and the skeletal response to intermittent parathyroid hormone. J. Endocrinol 189 (2006) 289-299
12. Yakar S., Rosen C.J., Beamer W.G., et al. Circulating levels of IGF-I directly regulate bone growth and density. J. Clin. Invest. 110 (2002) 771-781
13. McKnight B.J., and Goddard C. The effect of food restriction on circulating insulin-like growth factor-I in mice divergently selected for high or low protein or fat to body mass ratios. Comp.Biochem. Physiol. A 92 (1989) 565-569
14. Moriwake T., Abribat T., Brazeau P., and Ecarot B. Serum insulin-like growth factor finding protein-3 in the hypophosphatemic mouse: decreased activity and abnormal modulation by dietary phosphate. J. Bone Miner Res. 10 (1995) 1698-1704
15. Coschigano K.T., Clemmons D., Bellush L.L., and Kopchick J.J. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141 (2000) 2608-2613
16. Rosen C.J., Dimai H.P., Vereault D., et al. Circulating and skeletal insulin-like growth factor-I (IGF-I) concentrations in two inbred strains of mice with different bone mineral densities. Bone 21 (1997) 217-223
17. S. Yakar, J.L. Liu, B. Stannard, A., et al, Normal growth and development in the absence of hepatic insulin-like growth factor-I, Proc. Natl. Acad. Sci. 96 (1999) 7324-7329.
18. Sotelo A.I., Bartke A., Kopchick J.J., Knapp J.R., and Turyn D. Growth hormone (GH) receptors, binding protein and IGF-I concentrations in the serum of transgenic mice expressing bovine GH agonist or antagonist. J. Endocrinol. 158 (1998) 53-59
19. Cisneros F.J., Wilson R., Travlos G., Anderson L.M., and Branch S. Susceptibility to postnatal growth retardation induced by 5-AZA-2'-deoxycytidine in utero: gender specificity and correlation with reduced insulin-like growth factor I. Life Sci. 72 (2003) 2887-2894
20. Modric T., Silha J.V., Shi Z., et al. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142 (2001) 1958-1967
21. Yamamoto T., Matsuo S., Ueshima Y., Inoue F., Kinugasa A., and Sawada T. Plasma levels of insulin-like growth factor-I are reduced at one week of age in monosodium l-glutamate-treated mice. Endocrine J. 40 (1993) 461-465
22. Wang G.-M., O'Shaughnessy P.J., Chubb C., Bobaire B., and Hardy M.P. Effects of insulin-like growth factor-I on steroidogenic enzyme expression levels in mouse Leydig cells. Endocrinology 144 (2003) 5058-5064
23. Donahue L.R., and Beamer W.G. Growth hormone deficiency in "little" mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1, or -4. J. Endocrinol. 136 (1993) 91-104
24. Frystyk J., Grønbæk H., Skjærbæk C., Flyvbjerg A., Ørskov H., and Baxter R.C. Developmental changes in serum levels of free and total insulin-like growth factor-I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit in rats. Endocrinology 139 (1998) 4286-4292
25. Juul A., Dalgaard P., Blum W.F., et al. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J. Clin. Endocrinol. Metab. 80 (1995) 2534-2542
26. Juul A., Møller S., Mosfeldt-Laursen E., et al. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J. Clin. Endocrinol. Metab. 83 (1998) 4408-4415
27. Travers M.T., Madon R.J., and Flint D.J. Regulation of serum insulin-like growth factor-I (IGF-I), hepatic growth hormone binding and IGF-I gene expression in the rat during pregnancy and lactation. J. Endocrinol. 139 (1993) 89-95
28. Travers M.T., Madon R.J., Vallance A.J., and Barber M.C. Circulating concentrations and hepatic expression of IGF-I during pregnancy and lactation in the mouse. Biochem. Soc. Trans. 18 (1990) 1268
29. Monaghan J.M., Godber I.M., Lawson N., et al. Longitudinal changes of insulin-like growth factors and their binding proteins throughout normal pregnancy. Ann. Clin. Biochem. 41 (2004) 220-226
30. Heidler B., Parvizi N., Sauerwein H., et al. Effects of lactation on metabolic and reproductive hormones in Lipizzaner mares. Domestic Anim. Endocrinol. 25 (2003) 47-59
31. Gargosky S.E., Nanto-Salonen K., Tapanainen P., and Rosenfeld R.G. Pregnancy in growth hormone-deficient rats: assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity. J. Endocrinol. 136 (1993) 479-486
32. Fielder P.J., Thordarson G., Talamantes F., and Rosenfeld R.G. Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: effect of hypophysectomy and an IGFBP-specific serum protease activity. Endocrinology 127 (1990) 2270-2280
33. Giudice L.C., Farrell E.M., Pham H., Lamson G., and Rosenfeld R.G. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J. Clin. Endocrinol. Metab. 71 (1990) 806-816
34. Wiesli P., Zwimpfer C., Zapf J., and Schmid C. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3) and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Acta Obstet. Gynecol. Scand. 85 (2006) 900-905
35. Juul A., Main K., Blum W.F., Lindholm J., Ranke M.B., and Skakkebaek N.E. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin. Endocrinol. (Oxf) 41 (1994) 85-93
36. Baxter R.C., Svejkar M., Khosravi M.J., et al. Measurement of the acid-labile subunit of the insulin-like growth factor binding protein complex in human serum: a comparison of four immunoassays. J. Endocrinol. 165 (2000) 271-279
37. Kim J.W., Rhoads R.P., Segoale N., Kristensen N.B., Bauman D.E., and Boisclair Y.R. Isolation of the cDNA encoding the acid labile subunit (ALS) of the 150 kDa IGF-binding protein comples in cattle and ALS regulation during the transition from pregnancy to lactation. J. Endocrinol. 189 (2006) 583-593